Skip to main content

MINI REVIEW article

Front. Mol. Neurosci.

Sec. Pain Mechanisms and Modulators

Volume 18 - 2025 | doi: 10.3389/fnmol.2025.1547647

Environmental enrichment for neuropathic pain via modulation of neuroinflammation

Provisionally accepted
Jian-Dong Zhang Jian-Dong Zhang 1Zi-An Zhong Zi-An Zhong 2Wen-Yuan Xing Wen-Yuan Xing 2*
  • 1 Qilu Normal University, Jinan, China
  • 2 Shanghai University of Sport, Shanghai, Shanghai Municipality, China

The final, formatted version of the article will be published soon.

    Neuropathic pain causes tremendous biological and psychological suffering to patients worldwide. Environmental enrichment (EE) is a promising non-pharmacological strategy with high costeffectiveness to reduce neuropathic pain and support rehabilitation therapy. Three researchers reviewed previous studies to determine the efficacy of EE for neuropathic pain to research how EE improves neuropathic pain through neuroinflammation. For this review, Embase, PubMed, and Cochran were searched. Three authors did study selection and data extraction. Out of 74 papers, 7 studies met the inclusion criteria. In the chronic constriction injury rats with acute or chronic detrimental stimulation, the change of pain behavior was influenced by environmental settings like start time, and cage size. Besides, physical EE has a larger effect than socially EE in inflammatory pain. These articles suggest employing various EE to regulate the release of pain-causing substances and changes in ion channels in the peripheral and central nerves to improve neuropathic pain behavior and depression and anxiety conditions. The existing proof provides important knowledge for upcoming preclinical investigations and the practical use of EE in clinical pain treatment. This analysis aids in the advancement of improved approaches for managing chronic pain, with a focus on internal mechanisms for controlling pain.

    Keywords: environmental enrichment, neuropathic pain, Neuroinflammation, Cytokines, Chemokines Activating Transcription Factor 3, Arg-1: Arginase-1, BDNF: Brain-derived neurotrophic factor, CCI: Chronic Constriction Injury

    Received: 20 Dec 2024; Accepted: 06 Mar 2025.

    Copyright: © 2025 Zhang, Zhong and Xing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Wen-Yuan Xing, Shanghai University of Sport, Shanghai, 200072, Shanghai Municipality, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more